申请人:Pharmacyclics, Inc.
公开号:EP2865381A1
公开(公告)日:2015-04-29
Intracellular kinase inhibitors and their therapeutic uses for patients with T cell malignancies, B cell malignancies, autoimmune disorders, and transplanted organs.
细胞内激酶抑制剂及其对 T 细胞恶性肿瘤、B 细胞恶性肿瘤、自身免疫性疾病和移植器官患者的治疗用途。